Stay updated on Finerenone in HF with LVEF ≥40% Clinical Trial
Sign up to get notified when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.

Latest updates to the Finerenone in HF with LVEF ≥40% Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdds a government status notice and new FINEARTS-HF-related publications; removes several similar ahead-of-print citations. Overall, primary content and references updated rather than around pricing or availability.SummaryDifference4%
- Check19 days agoChange DetectedPage now shows Revision: v3.1.0 and removes several drug-safety topics; this indicates a restructuring/upgrade and streamlining of content related to drug safety topics.SummaryDifference0.1%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a new citation (Ostrominski et al.) and updated the page to v3.0.2; the v3.0.1 revision label was removed and the Back to Top element was deleted.SummaryDifference0.5%
- Check41 days agoChange DetectedThe page has been updated to include a new article on heart failure biomarkers and has removed a previous article on finerenone and frailty in heart failure, reflecting the latest research developments.SummaryDifference2%
- Check48 days agoChange DetectedThe webpage has been updated to include new facility names and locations, as well as detailed information about the FINEARTS-HF study, including its results and related publications. Notably, the study's focus has shifted to evaluating the efficacy and safety of Finerenone in heart failure patients.SummaryDifference100%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.0%
Stay in the know with updates to Finerenone in HF with LVEF ≥40% Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.